These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26887947)

  • 21. The Different Faces of the TDP-43 Low-Complexity Domain: The Formation of Liquid Droplets and Amyloid Fibrils.
    Chien HM; Lee CC; Huang JJ
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.
    Nonaka T; Kametani F; Arai T; Akiyama H; Hasegawa M
    Hum Mol Genet; 2009 Sep; 18(18):3353-64. PubMed ID: 19515851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.
    Saini A; Chauhan VS
    Chembiochem; 2011 Nov; 12(16):2495-501. PubMed ID: 21905193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.
    Johnson BS; McCaffery JM; Lindquist S; Gitler AD
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6439-44. PubMed ID: 18434538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
    Miguel L; Frébourg T; Campion D; Lecourtois M
    Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intracellular seeded aggregation of TDP-43].
    Nonaka T; Hasegawa M
    Rinsho Shinkeigaku; 2012; 52(11):1056-8. PubMed ID: 23196514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.
    Qin H; Lim LZ; Wei Y; Song J
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18619-24. PubMed ID: 25503365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.
    Budini M; Buratti E; Stuani C; Guarnaccia C; Romano V; De Conti L; Baralle FE
    J Biol Chem; 2012 Mar; 287(10):7512-25. PubMed ID: 22235134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43.
    Takagi S; Iguchi Y; Katsuno M; Ishigaki S; Ikenaka K; Fujioka Y; Honda D; Niwa J; Tanaka F; Watanabe H; Adachi H; Sobue G
    PLoS One; 2013; 8(6):e66966. PubMed ID: 23840565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice.
    Ding X; Xiang Z; Qin C; Chen Y; Tian H; Meng L; Xia D; Liu H; Song J; Fu J; Ma M; Wang X
    Acta Neuropathol Commun; 2021 Jan; 9(1):15. PubMed ID: 33461623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
    Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
    FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
    Lim L; Wei Y; Lu Y; Song J
    PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
    D'Alton S; Altshuler M; Cannon A; Dickson DW; Petrucelli L; Lewis J
    PLoS One; 2014; 9(1):e86513. PubMed ID: 24466128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 Prions.
    Nonaka T; Hasegawa M
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage.
    Kumar ST; Nazarov S; Porta S; Maharjan N; Cendrowska U; Kabani M; Finamore F; Xu Y; Lee VM; Lashuel HA
    Nat Neurosci; 2023 Jun; 26(6):983-996. PubMed ID: 37248338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
    Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
    Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates.
    Wang YT; Kuo PH; Chiang CH; Liang JR; Chen YR; Wang S; Shen JC; Yuan HS
    J Biol Chem; 2013 Mar; 288(13):9049-57. PubMed ID: 23372158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
    Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
    Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-like aggregation and fibril core determination of TDP-43 C-terminal domain.
    Chang Z; Deng J; Zhao W; Yang J
    Biochem Biophys Res Commun; 2020 Nov; 532(4):655-661. PubMed ID: 32907712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.
    Romano V; Quadri Z; Baralle FE; Buratti E
    Prion; 2015; 9(1):1-9. PubMed ID: 25635624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.